Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Muvalaplin (LY3473329) is an orally active lipoprotein (a) Lp(a) reagent that inhibits Lp(a) formation by blocking apo(a)-apo B100 interactions.
パッケージサイズ | 在庫状況 | 単価(税別) | |||
---|---|---|---|---|---|
サンプルについてお問い合わせ | |||||
1 mg | 在庫あり | ¥ 37,500 | |||
5 mg | 在庫あり | ¥ 94,500 | |||
10 mg | 在庫あり | ¥ 137,000 | |||
25 mg | 在庫あり | ¥ 224,000 | |||
50 mg | 在庫あり | ¥ 303,000 | |||
100 mg | 在庫あり | ¥ 406,500 |
説明 | Muvalaplin (LY3473329) is an orally active lipoprotein (a) Lp(a) reagent that inhibits Lp(a) formation by blocking apo(a)-apo B100 interactions. |
別名 | LY3473329 |
分子量 | 710.9 |
分子式 | C42H54N4O6 |
CAS No. | 2565656-70-2 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 10 mg/mL (14.07 mM), when pH is adjusted to 6. Sonication is recommended.
H2O: <0.1 mg/mL
You can also refer to dose conversion for different animals. 詳細
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Muvalaplin 2565656-70-2 Others LY-3473329 LY 3473329 LY3473329 Inhibitor inhibitor inhibit